Market Performance and Price Movement
On 13 Mar 2026, TTK Healthcare Ltd. opened sharply lower with a gap down of -3.91%, touching an intraday low of Rs.831.05, marking its lowest price point in the past year. The stock closed with a day change of -1.46%, underperforming its sector by -1.17%. This decline comes as the broader market also faced pressure, with the Sensex opening 590.20 points lower and trading at 75,268.60, down 1.01%. Several indices, including S&P Bse Dollex 30, NIFTY Realty, and NIFTY IT, also recorded new 52-week lows, signalling a widespread bearish sentiment.
TTK Healthcare is currently trading below all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – indicating sustained downward momentum. The Sensex itself is trading below its 50-day moving average, which is positioned below the 200-day moving average, reinforcing the overall bearish market context.
Long-Term and Recent Financial Trends
Over the last year, TTK Healthcare’s stock price has declined by 22.80%, contrasting with the Sensex’s modest gain of 1.87% over the same period. The stock has also underperformed the BSE500 index across multiple time frames, including the last three years, one year, and three months, highlighting persistent challenges in delivering shareholder returns.
Financially, the company’s long-term growth has been subdued. Net sales have increased at an annualised rate of 6.99% over the past five years, while operating profit has grown at 15.42% annually. These figures suggest moderate expansion but fall short of robust growth expectations for a diversified sector player.
In the most recent half-year results, cash and cash equivalents stood at Rs.600.89 crores, the lowest level recorded in recent periods. The debtors turnover ratio also declined to 7.40 times, indicating slower collection efficiency. Additionally, non-operating income accounted for 80.43% of profit before tax in the latest quarter, signalling a reliance on income sources outside core operations.
Built for the long haul! Consecutive quarters of strong growth landed this Small Cap from Chemicals on our Reliable Performers list. Sustainable gains are clearly ahead!
- - Long-term growth stock
- - Multi-quarter performance
- - Sustainable gains ahead
Shareholding and Market Perception
Despite its market presence, TTK Healthcare remains a micro-cap stock with a Mojo Score of 37.0 and a Mojo Grade of Sell, downgraded from Hold on 21 Jul 2025. Domestic mutual funds hold a minimal stake of just 0.01%, which may reflect limited institutional conviction or cautious positioning given the company’s recent performance and valuation.
Valuation and Profitability Metrics
The company maintains a low average debt-to-equity ratio of zero, indicating a conservative capital structure. Return on equity (ROE) stands at 6.5%, which, while modest, is accompanied by an attractive price-to-book value of 1.1. However, the stock trades at a premium relative to its peers’ historical valuations, which may contribute to investor hesitation amid subdued growth.
Profit growth over the past year has been limited, with a 2.4% increase despite the stock’s 22.60% decline in market value. The price/earnings to growth (PEG) ratio is elevated at 7.5, suggesting that the stock’s price does not align favourably with its earnings growth prospects.
Technical Indicators Signal Bearish Momentum
Technical analysis further underscores the stock’s current challenges. Weekly and monthly MACD indicators are bearish, as are Bollinger Bands and KST readings. The daily moving averages also reflect a bearish trend. While the monthly RSI shows some bullishness, other momentum indicators such as Dow Theory and On-Balance Volume (OBV) are mildly bearish on both weekly and monthly timeframes.
Considering TTK Healthcare Ltd.? Wait! SwitchER has found potentially better options in Diversified and beyond. Compare this micro-cap with top-rated alternatives now!
- - Better options discovered
- - Diversified + beyond scope
- - Top-rated alternatives ready
Context Within the Diversified Sector
TTK Healthcare operates within the diversified industry and sector, where growth and profitability metrics vary widely. Its micro-cap status and recent performance place it at a distinct position compared to larger peers. The stock’s 52-week high was Rs.1,402, indicating a significant retracement of approximately 40.7% from that peak to the current low of Rs.831.05.
Overall, the stock’s recent price action and financial indicators reflect a period of subdued performance and cautious market sentiment. The combination of below-average growth rates, limited institutional interest, and bearish technical signals has contributed to the stock’s decline to its lowest level in a year.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
